2023-06-29-世界卫生组织-COVID-19_Vaccine_Delivery_Partnership_-_Final_Situation_Report_21页_5mb

COVID-19 Vaccine Delivery Partnership (CoVDP) Final Report Summary

Global Situation

• By May 2023, 66% of the global population completed their primary COVID-19 vaccine series (47% in January 2022).
• Booster doses: 31% of the global population received at least one dose.
• Inequalities remain stark: Low-income countries (LICs) had significantly lower primary series coverage (27%) and booster uptake (3.5%) than high-income countries (HICs, 76% and 49%).
• Key high-priority groups:
  • Healthcare workers: 89% globally completed primary series (52% in LICs).
  • Older adults (≥60 y/o): 82% globally completed (only 3% in LICs).
• The CoVDP concludes its COVID-19 specific support by end-June 2023, transitioning responsibilities to core agencies (Gavi, UNICEF, WHO).

High-Priority Groups

• Significant coverage gaps persist:
  • Only 36% of healthcare workers and 3% of older adults in LICs completed primary series, much lower than global averages.
  • Booster uptake among high-priority groups is also low (7.5% healthcare workers, 3% older adults in LICs).

Advance Market Commitment (AMC) Countries

• Primary series coverage rose to 55% across the 92 countries/economies.
• Progress improved on global coverage figures, but gaps remain, especially in LICs.
• Booster uptake reached 16% of their populations.

34 Countries for Concerted Support

• Primary series coverage increased dramatically from 3% in January 2022 to 28% in May 2023 (>9-fold increase).
• Of the 34 countries, 28 have primary series coverage >10%, and almost half (>50%) now have coverage >30% (Sierra Leone, Tanzania, Zambia).
• Figures for high-priority groups and booster uptake remain low.

Key Lessons Learned

• Political leadership is essential for vaccine delivery and equity.
• Effective knowledge sharing and peer-to-peer collaboration (e.g., "One Plan, One Budget, One Team" approach) support integration.
• Flexible, quick funding mechanisms (Initiative for immediate disbursements) help address operational bottlenecks.
• Enhanced data systems and demand planning build resilience.

Operational Summary (CoVDP's Role)

• Provided technical support through missions, calls, and deployment of expertise to countries.
• Facilitated funding disbursements ($186 million to 21 countries) for COVID-19 vaccine activities.
• Coordinated partners (CoVDP Core Agencies) and maintained platforms for guidance and knowledge sharing.
• Post-transition, agencies (Gavi, UNICEF, WHO) and a new COVAX working group will manage COVID-19 vaccination support until the new Gavi COVID-19 program launches.

Conclusion

CoVDP successfully supported global COVID-19 vaccine delivery from January 2022 to May 2023, achieving significant coverage gains, particularly in LICs and humanitarian settings. Lessons learned will inform future public health emergency responses.